Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
1 of 4
Previous |
Next
Drug Discovery
Saving Drug Development Time with Digital Pathology
Why do I get my clinical data in weeks, and my pathology data in months?
No Comments
Increasing Your Return on Instrument Investment
Improving data quality and streamlining operations, while decreasing costs and drug development time, are ongoing goals for pharmaceutical labs. By Restek
No Comments
The Dream of Personalized Medicine
Next-generation sequencing takes us closer, but only if we have a sequence data management solution. With GenomeQuest
No Comments
Improving Clinical Trial Efficiency and Accuracy
Oncology clinical trials are expanding internationally while laboratory tests become increasingly complex. By Dr. Steven Potts, Worldwide Director, Biotech/Pharmaceutical, Aperio
No Comments
The Genetic Advantage
Allen Roses tells NGP how pharmacogenetics can help cut the size and cost of clinical trials.
No Comments
1 of 4
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.